Physician profile
David Valancy
NPI 1528635273
$1,972.87
in general payments reported to CMS, 2019-2025
13 companies · $380 in 2025
The $380 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $332 · 2023: $703 · 2024: $558 · 2025: $380.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,441 · Education: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,440.94 |
| Education | $199.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $409.94 | 2022-2024 | |
| Olympus America INC. | $397.85 | 2023-2025 | Itind System, Soltive |
| Boston Scientific Corporation | $397.36 | 2022-2025 | Spaceoar Vue System - 10ml, Ams 700 Cxr Rte Kit, Ams 800 Artificial Urinary Sphincter |
| Janssen Biotech, INC. | $235.26 | 2024-2025 | Akeega, Erleada, Carvykti |
| Progenics Pharmaceuticals, INC. | $157.01 | 2022-2025 | Pylarify |
| Angiodynamics, INC. | $140.55 | 2024-2025 | Nanoknife |
| Conmed Corporation | $59.91 | 2024 | Airseal |
| Sumitomo Pharma America, INC. | $41.45 | 2025 | Orgovyx |
| Antares Pharma, INC. | $37.03 | 2024 | Xyosted |
| Telix Pharmaceuticals | $29.62 | 2023 | Illuccix |
| Medtronic, INC. | $26.11 | 2024 | Interstim |
| Intuitive Surgical, INC. | $22.78 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.00 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Valancy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.